Patient care at Weill Cornell Medicine has not been materially impacted by a technology outage. READ MORE HERE

Dmitriy N. Feldman, M.D.


Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

Our group of experienced interventional cardiologists and vascular/endovascular specialists offers a comprehensive, multispecialty, cutting-edge approach to the evaluation and care of patients with coronary, peripheral and carotid arterial disease, with an emphasis on a minimally invasive endovascular approach. As an academic interventionalist, researcher and educator my goal is to deliver the best possible care to our patients and to provide them with access to the most innovative, state-of-the-art technology for treatment of coronary, peripheral vascular and carotid disease.

Biographical Info

Dr. Dmitriy N. Feldman is the Director of Endovascular Service of Interventional Cardiac and Endovascular Laboratory in the Division of Cardiology. He graduated Summa Cum Laude from New York University in December 1996 and received his Doctorate of Medicine degree from the Mount Sinai School of Medicine May 2001 in New York City. He completed his medical internship, residency in Internal Medicine, fellowship in Clinical Cardiology, and Interventional Cardiology Fellowship training at New York Presbyterian Hospital, Weill Cornell Medical College in New York City. He is board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology and Endovascular Medicine.

Dmitriy N. Feldman, M.D. is an Interventional Cardiologist specializing in angioplasty and stenting and one of Cornell's leaders in management of cardiovascular and peripheral vascular diseases on both inpatient and outpatient basis. His clinical expertise extends from the performance of complex coronary interventions to endovascular treatment of peripheral and carotid disease. His areas of research interest include percutaneous coronary and endovascular intervention outcomes research and he has performed extensive work with the New York State Department of Health PCI database, American College of Cardiology National Cardiovascular Data Registry as well as the Cornell Catheterization Laboratory institutional database. His area of research expertise includes the use of peri-procedural pharmacological agents, particularly bivalirudin, glycoprotein IIb/IIIa inhibitors, and thienopyridines. Dr. Feldman's research activities have been published in high impact journals such as Circulation, the Journal of American College of Cardiology, American Heart Journal, American Journal of Cardiology, and he has presented his findings at numerous national meetings including American Heart Association, American College of Cardiology, and Transcatheter Cardiovascular Therapeutics. He also serves as a peer reviewer for major high-impact medical journals such as Circulation, the LANCET and others.

Dmitriy N. Feldman, MD is a member of multiple professional societies: Fellow of American College of Cardiology (FACC), Fellow of Society for Cardiovascular Angiography and Interventions (FSCAI), Member of American Heart Association, Doctorate of Society for Vascular Medicine. He serves on Society for Cardiovascular Angiography and Interventions (SCAI) PVD committee and has been a passionate advocate in emphasizing importance of PVD and endovascular therapies. He has participated in writing consensus/expert documents with SCAI and ACC in the fields of coronary and peripheral vascular disease. Dr. Feldman has served as a principal investigator and coinvestigator on numerous trials and registries in coronary, structural heart, peripheral vascular and carotid disease areas of research. Dr. Feldman is one of Cornell's leaders in managing patients with resistant/refractory hypertension and evaluating novel percutaneous renal denervation therapy for those patients. He serves as a member of the Institutional Protocol Review Committee for Therapeutic and Interventional Studies and member of Vascular Service Line, Peripheral Intervention Quality Committee.

Dr. Feldman is currently appointed as a Director of Endovascular Cardiology Center for Vascular Care, an Assistant Professor of Medicine and an Assistant Attending Physician in the Interventional Cardiac and Endovascular Laboratory of the Greenberg Division of Cardiology.

A summary of Dr. Feldman's Education, Training and/or Faculty Appointments is listed as following:

2001 M.D. - The Mount Sinai School of Medicine

2002 Internship, Internal Medicine - NYPH - Cornell Campus

2004 Residency, Internal Medicine - NYPH - Cornell Campus

2007 Fellowship, Cardiology - NYPH - Cornell Campus

2008 Fellowship, Interventional Cardiology - NYPH - Cornell Campus

Other: Fellow, American College of Cardiology

Fellow, Society for Cardiovascular Angiography and Interventions

Doctorate, Society for Vascular Medicine

*Please note that Dr. Feldman is fluent in Russian.

Honors and Awards
  1. SCAI Emerging Leader Mentorship (ELM) Program Fellowship Recipient (in partnership with ACC and CRF) – 2013-2015
  2. The 5th Annual Department of Medicine Fellow Research Award (NY Presbyterian Weill Cornell Medical Center) - 2007
  3. Dr. Lee A. Winston, Ingersoll-Rand Company Award for the Senior Resident who Best Exemplifies Excellence in Clinical Care, Compassion and Humanitarianism - 2004
  4. Dr. Frederick H. King Medical Merit Scholarship for the Student Possessing the Most Excellent Scholastic Record - 1997-2001
  5. Dr. Henry S. Sacks Research Fellowship(NIH funded) - 1998
  6. Sigma Xi (The Scientific Research Society, NYU Chapter) - 1996
  7. Phi Beta Kappa (Beta Chapter of NY) - 1995
  8. Silverstein Scholarship (Merit Scholarship) - 1994
Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Cardiovascular Disease)
American Board of Internal Medicine (Interventional Cardiology)
American Board of Vascular Medicine
Clinical Expertise
Endovascular Medicine
Cardiac Catheterization
Vascular Medicine
Coronary Artery Disease
Arteriosclerotic Coronary Artery Disease
Peripheral Vascular Disease
Outcomes Research
Peripheral Stents
Coronary Angioplasty With Stent Placement
Coronary Angioplasty
Peripheral Angioplasty
Atherectomy, Endovascular
Carotid Artery Disease
Carotid Artery Stenting
Hypertensive Renovascular Disease
Renal Artery Stent Placement
Renal Artery Atherosclerosis
Deep Vein Thrombosis (DVT)
IVC Filter Retrieval
IVC Filter Placement
Poor Leg Circulation
Ischemic Ulcer of Lower Extremity
Lower Limb Ischemia
Extremity Atherosclerosis With Intermittent Claudication
PAOD (Peripheral Arterial Occlusive Disease)
Peripheral Arterial Disease
  • M.D.
    Mount Sinai School of Medicine
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Boston Scientific Corporation
Edwards Lifesciences Corp.
Merck & Co., Inc.